(Q38498943)
Statements
Lasofoxifene and cardiovascular events in postmenopausal women with osteoporosis: Five-year results from the Postmenopausal Evaluation and Risk Reduction with Lasofoxifene (PEARL) trial (English)
Andrea LaCroix
Steven Cummings
Elizabeth Barrett-Connor
Francine Welty
John R Thompson
David D Thompson
David M Reid
Slobodan Vukicevic
Roisin Armstrong
11 October 2010